Special biochemical researches for the estimation of efficiency of thrombolytic therapy at an ischemic stroke
Автор: Skorikova V.G., Kicherova O.A., Rejhert L.I., Semeshko S.A.
Журнал: Тюменский медицинский журнал @tmjournal
Статья в выпуске: 1 т.18, 2016 года.
Бесплатный доступ
The use of thrombolytic therapy in ischemic stroke helps to reduce oxidative stress and is associated with favorable changes in the structure of cell membranes. Established biomarkers of adverse prognosis in the thrombolytic therapy: Increased levels of matrix metalloproteinase-9, high sensitivity C-reactive protein of the blood plasma.
Ischemic stroke, thrombolytic therapy, oxidative stress, endothelial dysfunction, endogenous intoxication, matrix metalloproteinase-9
Короткий адрес: https://sciup.org/140220070
IDR: 140220070
Статья научная
